This product belongs to the 4-nitrogen steroid hormone compound, which is a specific type II 5alpha;-reductase competitive inhibitor, inhibiting the conversion of peripheral testosterone into dihydrotestosterone, and reducing the level of dihydrotestosterone in blood, prostate, skin and other tissues. By reducing the level of dihydrotestosterone in blood and prostate tissue, it inhibits prostate hyperplasia and improves the related clinical symptoms of benign prostatic hyperplasia.

No specific description provided

This product is an angiotensin II receptor (AT1 type) antagonist. It can block various pharmacological effects of endogenous and exogenous angiotensin II (including vasoconstriction, aldosterone release, etc.); this product can selectively act on AT1 receptors, does not affect the functions of other hormone receptors or important ion channels in the cardiovascular system, does not inhibit angiotensin converting enzyme (kininase II) that degrades bradykinin, and does not affect the metabolic process of angiotensin II and bradykinin.

Losartan is a synthetic, potent, orally active drug that can selectively bind to the AT1 receptor and block the corresponding physiological effects of angiotensin II synthesized from any source or pathway. It does not affect the functions of other hormone receptors or important ion channels in the cardiovascular system, nor does it inhibit angiotensin converting enzyme (kininase II) that degrades bradykinin.

Azithromycin is a 15-membered macrolide antibiotic that inhibits RNA-dependent protein synthesis by binding to the 50S subunit of bacterial ribosomes. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms.